Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (371-380 of 587) with videos related to

Pageof 59
Sort By:
The Journal of Investigative Dermatology|July 26, 2003
Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patientStefania Mantovani, Silvia Garbelli, Belinda Palermo, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 28, 2013
Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatmentRiccardo Caccialanza, Giovanni Palladini, Catherine Klersy, et al.
BMJ Open|February 18, 2019
Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancerOriana Ciani, Maria Cucciniello, Francesco Petracca, et al.
Blood|January 26, 2006
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in ALGiovanni Palladini, Francesca Lavatelli, Paola Russo, et al.
Nature Communications|March 9, 2019
Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloidsFalk Liberta, Sarah Loerch, Matthies Rennegarbe, et al.
Diabetes Care|July 29, 2003
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patientsMichael Alvarsson, Göran Sundkvist, Ibe Lager, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 15, 2022
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working groupAshutosh D Wechalekar, M Teresa Cibeira, Simon D Gibbs, et al.
Lancet (London, England)|March 11, 2015
Rare diseases and effective treatments: are we delivering?Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Disease Models & Mechanisms|July 25, 2025
Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegansMargherita Romeo, Maria Monica Barzago, Alessandro Corbelli, et al.
Chemical Reviews|January 11, 2021
Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II DiabetesDanilo Milardi, Ehud Gazit, Sheena E Radford, et al.
Pageof 59

Showing results (371-380 of 587) with videos related to

Sort By:
Pageof 59
The Journal of Investigative Dermatology|July 26, 2003
Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patientStefania Mantovani, Silvia Garbelli, Belinda Palermo, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 28, 2013
Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatmentRiccardo Caccialanza, Giovanni Palladini, Catherine Klersy, et al.
BMJ Open|February 18, 2019
Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancerOriana Ciani, Maria Cucciniello, Francesco Petracca, et al.
Blood|January 26, 2006
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in ALGiovanni Palladini, Francesca Lavatelli, Paola Russo, et al.
Nature Communications|March 9, 2019
Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloidsFalk Liberta, Sarah Loerch, Matthies Rennegarbe, et al.
Diabetes Care|July 29, 2003
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patientsMichael Alvarsson, Göran Sundkvist, Ibe Lager, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 15, 2022
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working groupAshutosh D Wechalekar, M Teresa Cibeira, Simon D Gibbs, et al.
Lancet (London, England)|March 11, 2015
Rare diseases and effective treatments: are we delivering?Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Disease Models & Mechanisms|July 25, 2025
Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegansMargherita Romeo, Maria Monica Barzago, Alessandro Corbelli, et al.
Chemical Reviews|January 11, 2021
Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II DiabetesDanilo Milardi, Ehud Gazit, Sheena E Radford, et al.
Pageof 59